Skip to content
OpenCapital
Get started

Core Laboratories CLB Long-Term Debt and Finance Lease Obligations

Long-Term Debt and Finance Lease Obligations at other companies

NCS Multistage Holdings logo
NCS Multistage HoldingsNCSM
——
Baker Hughes logo
Baker HughesBKR
——
Weatherford International logo
Weatherford InternationalWFRD
——
Innovex International logo
Innovex InternationalINVX
——

Other financials

Income statement

See full
Revenue$121.8M-1.4%
Operating income$1.9M-57.3%
Net income-$789.0K-412%
EPS (diluted)-$0.02—

Balance sheet

See full
Cash & equivalents$22.8M+3.2%
Total debt$167.8M-6.8%
Total equity$268.9M+6.1%
Total assets$587.7M+0.3%

Cash flow

See full
Operating cash flow$4.0M-40.5%
CapEx$3.4M+23.8%
Free cash flow$517.0K-86.7%

Valuation

See full
Market cap$537.03M-4.5%
Enterprise value$682.05M-3.9%
P/E18.5×-0.5×
P/S1×-0.1×

Profitability

See full
Operating margin10.3%-0.2pp
Net margin5.5%+0.1pp
FCF margin4.3%-4.6pp

Returns & leverage

See full
Return on equity11.1%-0.4pp
Debt / equity0.6×-0.1×
Current ratio2×-0.2×

Where this comes from

Reported directly by Core Laboratories in its filing.

Tagged under the XBRL concept us-gaap:LongTermDebtAndCapitalLeaseObligations.

The official record: Core Laboratories’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Core Laboratories's long-term debt and finance lease obligations.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Core Laboratories's long-term debt and finance lease obligations?
Core Laboratories (CLB) reported long-term debt and finance lease obligations of $114.46M in Q1 2026.
How has Core Laboratories's long-term debt and finance lease obligations changed year-over-year?
Core Laboratories's long-term debt and finance lease obligations decreased by 8.0% year-over-year, from $124.37M to $114.46M.
What is the long-term trend for Core Laboratories's long-term debt and finance lease obligations?
Over 3 years (2022 to 2025), Core Laboratories's long-term debt and finance lease obligations has grown at a -13.8% compound annual growth rate (CAGR), from $172.39M to $110.26M.